AArly DETECT 2 feasibility study designed to validate earlier results on advanced adenomas over a large population of average risk patients. Multi-center study expected to comple ...
IntelliGenome, an innovative molecular diagnostic solutions provider, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its ...
On January 14, a 25-year-old Quarter Horse mare in Tuscola County, Michigan, tested positive for strangles after developing nasal discharge and swollen lymph nodes. Two additional horses on the ...